A role for transcription factor E2F2 in hepatocyte proliferation and timely liver regeneration

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 1, 2011, Pages

  Delgado, Igotz ^a   Fresnedo, Olatz ^a   Iglesias, Ainhoa ^b   Rueda, Yuri ^a   Syn, Wing Kin ^a,c   Zubiaga, Ana M ^b   Ochoa, Begoña ^a  

^a Faculty of Medicine   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c University Hospital Birmingham NHS Foundation Trust   (United Kingdom)

Author keywords

Cell cycle; Liver repair; Partial hepatectomy; Transcriptome

Indexed keywords

TRANSCRIPTION FACTOR E2F2; TRANSCRIPTOME;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GENE INTERACTION; INTRACELLULAR TRANSPORT; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER REGENERATION; LOSS OF FUNCTION MUTATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; WILD TYPE; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; E2F2 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION PROFILING; HEPATOCYTES; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 79959849579     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00481.2010     Document Type: Article

References (48)

1. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, Montaner D, Dopazo J. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 35: W91-W96, 2007.
2. Aslanian A, Iaquinta PJ, Verona R, Lees JA. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev 18: 1413-1422, 2004.
3. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 71: 333-374, 2002.
4. Bracken AP, Ciro M, Cocito A, Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci 29: 409-417, 2004.
5. Cao Y, Traer E, Zimmerman GA, McIntyre TM, Prescott SM. Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics 49: 327-330, 1998.
6. Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene 19: 5054-5062, 2000.
7. Chong JL, Wenzel PL, Sáenz-Robles MT, Nair V, Ferrey A, Hagan JP, et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462: 930-934, 2009.
8. Degregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta 1602: 131-150, 2002.
9. Degregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6: 739-748, 2006.
10. Delahunty TJ, Rubinstein D. Accumulation and release of triglycerides by rat liver following partial hepatectomy. J Lipid Res 11: 536-543, 1970.
11. DePamphilis ML. Cell cycle dependent regulation of the origin recognition complex. Cell Cycle 4: 70-79, 2005.
12. Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24: 2810-2826, 2005.
13. Dirlam A, Spike BT, Macleod KF. Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts. Mol Cell Biol 27: 8713-8728, 2007.
14. Dong HM, Xu CS. Analysis of the relevance of e2fs and their target genes with rat liver regeneration. Indian J Gastroenterol 27: 31-32, 2008.
15. Fujita M, Kiyono T, Hayashi Y, Ishibashi M. hCDC47, a human member of the MCM family. Dissociation of the nucleus-bound form during S phase. J Biol Chem 271: 4349-4354, 1996.
16. Guerrieri F, Muolo L, Cocco T, Capozza G, Turturro N, Cantatore P, Papa S. Correlation between rat liver regeneration and mitochondrial energy metabolism. Biochim Biophys Acta 1272: 95-100, 1995.
17. Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, Moreno B, Lloreta J, Field SJ, Real FX, Zubiaga AM. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J Clin Invest 113: 1398-1407, 2004.
18. Infante A, Laresgoiti U, Fernandez-Rueda J, Fullaondo A, Galan J, Díaz-Uriarte R, Malumbres M, Field SJ, Zubiaga AM. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle 7: 3915-3927, 2008.
19. Leclercq IA, Field J, Farrell GC. Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124: 1451-1464, 2003.
20. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 20: 3626-3632, 2000.
21. Li FX, Zhu JW, Hogan CJ, Degregori J. Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice. Mol Cell Biol 23: 3607-3622, 2003.
22. Lukas ER, Bartley SM, Graveel CR, Diaz ZM, Dyson N, Harlow E, Yamasaki L, Farnham PJ. No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Mol Carcinog 25: 295-303, 1999.
23. Lukas J, Petersen BO, Holm K, Bartek J, Helin K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 16: 1047-1057, 1996.
24. Michalopoulos GK. Liver regeneration. J Cell Physiol 213: 286-300, 2007.
25. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267-285, 2001.
26. Murga M, Fernandez-Capetillo O, Field SJ, Moreno B, Borlado LR, Fujiwara Y, Balomenos D, Vicario A, Carrera AC, Orkin SH, Greenberg ME, Zubiaga AM. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15: 959-970, 2001.
27. Newberry EP, Kennedy SM, Xie Y, Luo J, Stanley SE, Semenkovich CF, Crooke RM, Graham MJ, Davidson NO. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology 48: 1097-1105, 2008.
28. Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, Nojima H. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18: 2299-2309, 1999.
29. Opavsky R, Tsai SY, Guimond M, Arora A, Opavska J, Becknell B, Kaufmann M, Walton NA, Stephens JA, Fernandez SA, Muthusamy N, Felsher DW, Porcu P, Caligiuri MA, Leone G. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci USA 104: 15400-15405, 2007.
30. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, Abeygunawardena N, Berube H, Dylag M, Emam I, Farne A, Holloway E, Lukk M, Malone J, Mani R, Pilicheva E, Rayner TF, Rezwan F, Sharma A, Williams E, Bradley XZ, Adamusiak T, Brandizi M, Burdett T, Coulson R, Krestyaninova M, Kurnosov P, Maguire E, Neogi SG, Rocca-Serra P, Sansone SA, Sklyar N, Zhao M, Sarkans U, Brazma A. ArrayExpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 37: D868-D872, 2009.
31. Persengiev SP, Li J, Poulin ML, Kilpatrick DL. E2F2 converts reversibly differentiated PC12 cells to an irreversible, neurotrophin-dependent state. Oncogene 20: 5124-5131, 2001.
32. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003.
33. Sanders JA, Gruppuso PA. Coordinated regulation of c-Myc and Max in rat liver development. Am J Physiol Gastrointest Liver Physiol 290: G145-G155, 2006.
34. Scheijen B, Bronk M, van der Meer T, De Jong D, Bernards R. High incidence of thymic epithelial tumors in E2F2 transgenic mice. J Biol Chem 279: 10476-10483, 2004.
35. Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 40: 1322-1332, 2004.
36. Suzuki S, Adachi A, Hiraiwa A, Ohashi M, Ishibashi M, Kiyono T. Cloning and characterization of human MCM7 promoter. Gene 216: 85-91, 1998.
37. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: 561-568.
38. Takahashi Y, Rayman JB, Dynlacht BD. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816, 2000.
39. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5: 836-847, 2004.
40. Tijburg LB, Nyathi CB, Meijer GW, Geelen MJ. Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy. Biochem J 277: 723-728, 1991.
41. Togo S, Makino H, Kobayashi T, Morita T, Shimizu T, Kubota T, Ichikawa Y, Ishikawa T, Okazaki Y, Hayashizaki Y, Shimada H. Mechanism of liver regeneration after partial hepatectomy using mouse cDNA microarray. J Hepatol 40: 464-471, 2004.
42. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3: 11-20, 2002.
43. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 19: 6379-6395, 1999.
44. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20: 5797-5807, 2000.
45. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414: 457-462, 2001.
46. Yamauchi H, Uetsuka K, Okada T, Nakayama H, Doi K. Impaired liver regeneration after partial hepatectomy in db/db mice. Exp Toxicol Pathol 54: 281-286, 2003.
47. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34: 694-706, 2001.
48. Zhu JW, Field SJ, Gore L, Thompson M, Yang H, Fujiwara Y, Cardiff RD, Greenberg M, Orkin SH, DeGregori J. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol 21: 8547-8564, 2001.